Bolland, Mark J <br/><br/>
Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Apr 2007 
 - 1283-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-972X 
<br/><br/><label>Standard No.: </label>10.1210/jc.2006-2216  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiretroviral Therapy, Highly Active<br/>Body Mass Index<br/>Body Size<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--administration & dosage<br/>Diphosphonates--administration & dosage<br/>Drug Administration Schedule<br/>HIV Infections--drug therapy<br/>Humans<br/>Imidazoles--administration & dosage<br/>Male<br/>Middle Aged<br/>Placebos<br/>Zoledronic Acid